{
    "SPADE_N_13946": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_13946",
            "Peptide Name": "Hill-Cec4 (UCLL1, XXA, cecropin, natural AMPs;insects, arthropods, invertebrates, animals; Variant: H4)",
            "Source": "the Black Soldier Fly,Hermetia Illucens",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "GWWKRVFKPVERLGQRVRDAGIQGLQIAQQGANVLATVRGGPPQQ",
            "Sequence Length": 45,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 4967.65,
            "PI": 11.83,
            "Hydrophobicity": -0.53,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Van Moll L, De Smet J, Paas A, Tegtmeier D, Vilcinskas A, Cos P, Van Campenhout L.2022",
                    "Reference": "Microbiol Spectr. 2022 Feb 23;10(1):e0166421. doi: 10.1128/spectrum.01664-21.Pub-Med.",
                    "Title": "In Vitro Evaluation of Antimicrobial Peptides from the Black Soldier Fly (Hermetia Illucens) against a Selection of Human Pathogens."
                }
            ],
            "Frequent Amino Acids": "GQR",
            "Absent Amino Acids": "CHMOSUY",
            "Basic Residues": 7,
            "Acidic Residues": 2,
            "Hydrophobic Residues": 20,
            "Polar Residues": 25,
            "Positive Residues": 7,
            "Negative Residues": 2,
            "Net Charge": 5,
            "Comments": "Sequence analysis: APD analysis reveals this sequence is most similar (93.33%) toHill-Cec3Activity: active against S-aureus ATCC 6538 (MIC >32-64 uM), E. coli ATCC 8739 (MIC 1-2 uM), P. aeruginos (MIC 1-2 uM).Discovery: this sequence has also been reported in a different paper where the C-terminal G is converted to C-terminal amidation in this sequence. Peptide H4 is active against E. coli ATCC25922 (MIC 1.6 uM), K. pneumoniae ATCC700603 (MIC 6.5 uM), A.baumannii ATCC19606 (MIC 6.5 uM), P-aeruginosa CMCC10104(MIC >26 uM), V. parahaemolyticus ATCC17802 (MIC 3.2 uM), E-faecalis ATCC29212 (MIC >26 uM), B. subtilis BNCC109047 (MIC 1.6 uM), S-epidermidis ATCC35984 (MIC >26 uM), S-aureus ATCC6538 (MIC >26 uM), and C-albicans ATCC10231 (MIC > 26 uM) (Peng et al., 2023).",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_15380",
                    "Similarity": 1.0,
                    "Sequence": "GWWKRVFKPVERLGQRVRDAGIQGLQIAQQGANVLATVRGGPPQQG"
                },
                {
                    "SPADE_ID": "SPADE_N_14001",
                    "Similarity": 0.9777777777777777,
                    "Sequence": "GWWKRVFKPVERLGQRVRDAGIQGLEIAQQGANVLATVRGGPPQQG"
                },
                {
                    "SPADE_ID": "SPADE_N_15383",
                    "Similarity": 0.9777777777777777,
                    "Sequence": "GWWKRVFKPVEKLGQRVRDAGIQGLQIAQQGANVLATVRGGPPQQG"
                }
            ]
        }
    }
}